The next time you see a bag of Epsom salt on sale, grab it. You‘ll be ready to tackle everything from tired feet to tomato plants with the confidence of someone who knows that frugality isn’t just about saving money—it’s about making the most of what you have. And if nothing else, it’ll give you one more thing to brag about at your next PTA meeting. “Oh, you spent $20 on grout cleaner? I made mine with Epsom salt and dish soap.” Cue the applause.

Epsom salt is often overlooked despite its numerous uses and benefits. It is an affordable and versatile item that deserves more attention in the household.

Epsom salt is a naturally occurring mineral compound of magnesium and sulfate, not to be confused with edible table salt, which is sodium chloride. Discovered in Epsom, Surrey, England, it has been utilized for centuries for various purposes, including relieving muscle aches, gardening, and household maintenance.

Relieve Muscle Pain

To soothe aching muscles, add one or two cups of Epsom salt to a warm bath and soak for 15 to 20 minutes.

Why It Works: The magnesium in Epsom salt aids in muscle relaxation and reduces inflammation, making it an excellent choice for post-exercise recovery or after strenuous activities.

Remove stye's from eyes.  Dissolve Epsom Salt in a dish of boiling water when cooled sufficiently bath the eye. in Two or three treatments the stye will disappear and never return.

Why it works. Epsom Salt is anti-inflammatory and it kills the bacteria causing the stye.

Create a DIY Body Scrub

Combine Epsom salt with olive oil or coconut oil to create an exfoliating scrub. Adding essential oils can enhance the fragrance if desired.

Why It Works: Epsom salt's abrasive texture efficiently exfoliates dead skin cells while remaining gentle enough for regular use.

Extract Splinters

Dissolve one tablespoon of Epsom salt in warm water and soak the affected area.

Why It Works: The anti-inflammatory properties of Epsom salt help draw out the splinter and reduce inflammation around the area.

Enhance Plant Growth

Apply a tablespoon or two of Epsom salt to the base of plants, or dissolve it in water and spray on the leaves.

Why It Works: Magnesium and sulfate are vital nutrients for plant growth, particularly for tomatoes, peppers, and roses. This method provides a cost-effective alternative to specialty fertilizers.

Revitalize Feet

Add half a cup of Epsom salt to a basin of warm water and soak your feet.

Why It Works: Epsom salt softens calluses and soothes soreness, providing much-needed relief and care for your feet.

Clean Tile and Grout

Mix equal parts of Epsom salt and Blue Dawn dish soap. Use the mixture to scrub tile and grout.

Why It Works: The combination of Epsom salt's abrasiveness and Blue Dawn's degreasing ability effectively cleans without the need for harsh chemicals.

Increase Hair Volume

Blend equal parts of Epsom salt and conditioner. Apply to hair, leave for 10 minutes, and rinse thoroughly.

Why It Works: Epsom salt helps remove excess oil and buildup, enhancing hair volume and appearance.

Clean Cookware

Sprinkle Epsom salt on burnt-on food and scrub with a sponge.

Why It Works: Epsom salt's coarse texture aids in removing stubborn residue without damaging cookware.

Repel Garden Pests

Spread Epsom salt around the garden to deter slugs and snails.

Why It Works: Slugs and snails avoid Epsom salt, allowing you to protect your garden naturally and economically.

Improve Sleep Quality

Take an Epsom salt bath before bedtime.

Why It Works: Magnesium can help improve sleep quality, making Epsom salt baths a relaxing and beneficial pre-sleep ritual.

Remove Blackheads

Mix one teaspoon of Epsom salt with warm water and a few drops of iodine. Apply with a cotton ball, let it sit for a minute, and rinse.

Why It Works: This mixture helps loosen blackheads and cleanse pores efficiently.

Conclusion

Epsom salt is an invaluable and economical tool for a variety of applications. Its diverse uses, from soothing tired muscles to enhancing plant growth, make it a valuable addition to any household. When you next find Epsom salt on sale, consider purchasing it to leverage its many benefits, thus demonstrating both frugality and resourcefulness.

Famous holistic author, naturopath and researcher Ann Boroch was found dead in Los Angeles on Thursday, as the community of physicians seeking to operate outside the confines of Big Pharma continues to be decimated. She was 51.

Ann Boroch, the author of Healing Multiple Sclerosis and The Candida Cure, was famous for curing herself of multiple sclerosis at the age of 24, and remaining symptom free for over two decades.

Boroch was also outspoken on many issues including the dangers of vaccination, and she was actively campaigning for people to take control of their lives and reject Big Pharma’s crippling products in favor of natural healing. She believed that education is the most important tool to heal your mind and body.

Her sudden and unexpected death has left her family and supporters in such a state of shock that her cousin Lisa had to confirm on Facebook that the news was unfortunately correct.

From her official Facebook page:

“It is with a heavy heart we share with you that Ann Boroch, passed away suddenly on Tuesday, August 1, 2017. Many of you are familiar with Ann’s story…..

“Throughout her early 20’s, she battled Multiple Sclerosis. When traditional medicine provided no relief, she created her own self-help program and discovered that yeast and fungal toxins are the main culprit in autoimmune disease. By diligently maintaining a strict candida diet, Ann was able to cure herself of MS. Grateful for the healing triumph, she realized that it had become her mission to educate the public.

“Ann went back to school and became a naturopath, certified clinical hypnotherapist and certified nutritional consultant. After that, Ann opened her own practice in Los Angeles, and for almost 20 years has been the guiding light to healing for thousands of people around the world.”

[Days After Holistic Author’s Death, Her Work Is Scrubbed From Internet]

A selection of Ann Boroch’s published works.

Ann Boroch Facebook Page

Over 60 holistic doctors and researchers have been found dead in the past 18 months, most of whom died in suspicious and unsolved circumstances.

Check out some of Ann Boroch’s TV appearances below. Her decades of study meant she had much wisdom to share.

https://www.youtube.com/watch?v=Dc-wDN1MUuo&feature=youtu.be

https://www.youtube.com/watch?v=zPiHuvuP7mo&feature=youtu.be

SOURCE 

A Danish scientific study warns that children vaccinated with the DTP vaccine may face a mortality rate up to ten times higher than their unvaccinated peers. 

While the CDC and the World Health Organization refuse to perform vaccine safety studies or publish reports on vaccinated vs. unvaccinated children, the data from the Danish government study lends further weight to the argument that the public have a right to know more about vaccine safety.

The rare study, funded in part by the Danish government and led by Dr. Soren Wengel Mogensen, was published in January in EBioMedicine.

Dr. Mogensen and his team of scientists found that African children inoculated with the DTP (diphtheria, tetanus and pertussis) vaccine had a 5-10 times greater mortality rate than their unvaccinated peers.

The data suggests that, while the vaccine may protect against infection from those three bacteria, it significantly weakens the immune system and damages overall health, making children more susceptible to dying from other causes.

Worldmercuryproject.org reports: The scientists term the study a “natural experiment” since a birthday-based vaccination system employed for the Bandim Health Project (BHP) in Guinea Bissau, West Africa had the effect of creating a vaccinated cohort and a similarly situated unvaccinated control group.

In the time period covered by this study, Guinea-Bissau had 50% child mortality rates for children up to age 5. Starting in 1978, BHP health care workers contacted pregnant mothers and encouraged them to visit infant weighing sessions provided by a BHP team every three months after their child’s birth.

Beginning in 1981, BHP offered vaccinations at the weighing sessions.  Since the DPT vaccine and OPV (oral polio) immunizations were offered only to children who were at least three months of age at the weighing sessions, the children’s random birthdays allowed for analysis of deaths between 3 and 5 months of age depending on vaccination status.

So, for example, a child born on January 1st and weighed on April 1st would be vaccinated, but a child born on February 1st would not be vaccinated until their following visit at age 5 months on July 1st.

In the primary analysis, DTP-vaccinated infants experienced mortalities five times greater than DTP-unvaccinated infants.

Mortalities to vaccinated girls were 9.98 times those among females in the unvaccinated control group, while mortalities to vaccinated boys were 3.93 times the controls.

Oddly, the scientists found that children receiving the oral polio vaccine simultaneously with DTP fared much better than children who did not.  The OPV vaccine appeared to modify the negative effect of the DTP vaccine, reducing mortalities to 3.52 times those experienced among the control group.

Overall, mortalities among vaccinated children were 10 times the control group when children received only the DTP.

Mogensen and his colleagues hypothesize that the DTP vaccine might weaken a child’s immune system against non-target infections.

They conclude, “Though protective against the target disease, DTP may increase susceptibility to unrelated infections… DTP was associated with 5-fold higher mortality than being unvaccinated.  No prospective study has shown beneficial survival effects of DTP.”

The Mogensen study supports the conclusions of previous investigations into child survival following vaccination.  An earlier study by Dr. Peter Aaby, of the introduction of DTP in rural Guinea-Bissau, indicated a 2-fold higher mortality among vaccinated children (Aaby et al. 2004a).  The Aaby report is one of several early studies that documented vaccination status and followed children prospectively.

All of them indicated that DTP-vaccinated children died at rates far exceeding mortality amongst the control group.  A meta-analysis of all eight known studies found a two-fold higher mortality for DTP-vaccinated compared to DTP-unvaccinated (Aaby et al. 2016) (Appendix A).

In 2014, The World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) conducted its own literature review of the potential non-specific effects (NSEs) of several vaccines, including DTP, and found that the majority of studies reported a detrimental effect of DTP (Higgins et al., 2014; Strategic Advisory Group of Experts of Immunization, 2014) due to its penchant for increasing susceptibility to unrelated infections.  SAGE recommended further research.

Moreover, Mogensen and his colleagues observe that the studies reviewed by SAGE probably underestimated the lethal effect of the DTP vaccine because of unusually high mortality in the control groups, ”Unvaccinated children in these studies have usually been frail children too sick or malnourished to get vaccinated and the studies may therefore have underestimated the negative effect of DTP”.

The Mogensen study sought to avoid this pitfall by using controls selected by birthday and by eliminating underweight children and orphans from both the study group and the control group.

It included only children who were breastfed.  All the infants were healthy at the time of vaccination.  Nevertheless, the Mogensen authors point out that, even in their study, the unvaccinated children had slightly worse nutritional status and travelled more – biases that would tend to increase mortality.

They conclude that, “The estimate from the natural experiment may therefore still be conservative.”

The significance of the Mogensen study findings is underscored by the observation that, “Unfortunately, DTP is the most widely used vaccine, and the proportion who receives DTP3 is used globally as an indicator of the performance of national vaccination programs.”

The authors close with a bracing rebuke to public health regulators, “It should be of concern that the effect of routine vaccinations on all-cause mortality was not tested in randomized trials.  All currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis.  Though a vaccine protects children against the target disease it may simultaneously increase susceptibility to unrelated infections.”

Those words should serve as a cold water wake-up call to the World Health Organization (WHO), the CDC and other public health officials.

The public in both poor and rich countries has a right to scientifically-based evidence that international vaccine programs are as safe as possible and that they have been thoroughly safety-tested.  The best metrics for measuring safety are studies comparing health outcomes of vaccinated versus unvaccinated cohorts.  Yet, both the CDC and the WHO have aggressively discouraged the pursuit of such studies.

Finally, it’s important to note that the DTP vaccine used in Guinea-Bissau in the early 1980s almost certainly contained high concentrations of both mercury and aluminum. Vaccine makers first created the combined diphtheria, tetanus and pertussis vaccine in the 1940s, mixing in an aluminum adjuvant and a mercury preservative (thimerosal) from its inception.  At that time, the American Academy of Pediatrics recommended DTP for mass use in children. Prior to 1990, DTP was the only thimerosal-containing vaccine recommended for infants.

Five manufacturers supplied UNICEF with the DTP vaccines used in West Africa in the late 1970s and early 1980s.  One of these, Biken of Japan, described the industry standard in its 1987 lab report: “Outline of Method of Manufacture—The preparation [of DTP] also contains thimerosal as a preservative.”

By the early 1980s, a cascade of lawsuits filed across the United States on behalf of vaccine-injured children were driving DTP manufacturers from the market and threatening to shut down production of the DTP shot and other vaccines.

That threat led the U.S. Congress to bestow legal immunity on vaccine makers via the National Childhood Vaccine Injury Program in 1986, followed in December, 1987, by the rollout of “Vaccine Court.”

Following the recommendation by the Institute of Medicine, vaccine makers removed thimerosal from the American DTaP between 2001-2003.  However, multi-dose DTP vaccines given to tens of millions of children across the African continent continue to contain massive doses of thimerosal (25mcg of ethylmercury per injection) that exceed the EPA’s maximum exposure levels by many times.

Neither the CDC nor the WHO has ever published a vaccinated vs. unvaccinated study that would be necessary to determine the overall health impacts of this potent toxin on African children.

The Mogensen report is a loud call for such a study.